Background <p>The care of women with inflammatory bowel disease (IBD) presents unique challenges for physicians given the impact of their disease on the management of issues throughout their lifespan. Preventative care plays a critical role, given the long-term sequelae associated with chronic inflammation and immunosuppressive therapy. Despite this, there remains a gap in knowledge regarding the health maintenance needs of women over 40, particularly those in perimenopausal and postmenopausal stages. This is especially important given the first cohort of patients treated with novel IBD therapies, including biologic agents, are approaching advanced age.</p> Objective <p>To review the health maintenance needs and clinical recommendations for the perimenopausal and postmenopausal woman with IBD.</p> Results <p>Key areas of focus include sexual and reproductive health, menopause-related concerns, prevention and screening of cervical and breast cancer, osteoporosis, and atherosclerotic disease. We summarize current guidelines and available literature, and discuss gaps in existing literature.</p> Conclusion <p>As the population of women with IBD age, individualized care for this population is increasingly important. This review highlights key health maintenance needs and provides a practical overview to care for this commonly overlooked patient population.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Health Maintenance and Unique Health Needs of the Perimenopausal and Postmenopausal Woman with Inflammatory Bowel Disease

  • Grace Wang,
  • Carmen Ching,
  • Youstina Hanna,
  • Parul Tandon,
  • Vivian Huang

摘要

Background

The care of women with inflammatory bowel disease (IBD) presents unique challenges for physicians given the impact of their disease on the management of issues throughout their lifespan. Preventative care plays a critical role, given the long-term sequelae associated with chronic inflammation and immunosuppressive therapy. Despite this, there remains a gap in knowledge regarding the health maintenance needs of women over 40, particularly those in perimenopausal and postmenopausal stages. This is especially important given the first cohort of patients treated with novel IBD therapies, including biologic agents, are approaching advanced age.

Objective

To review the health maintenance needs and clinical recommendations for the perimenopausal and postmenopausal woman with IBD.

Results

Key areas of focus include sexual and reproductive health, menopause-related concerns, prevention and screening of cervical and breast cancer, osteoporosis, and atherosclerotic disease. We summarize current guidelines and available literature, and discuss gaps in existing literature.

Conclusion

As the population of women with IBD age, individualized care for this population is increasingly important. This review highlights key health maintenance needs and provides a practical overview to care for this commonly overlooked patient population.